Nose and paranasal sinuses: allergen immunotherapy: practice question

A ENT question in the style of the NEET PG paper. Answer it first, then read why the right option is right and why each of the others is wrong.

Try it

ENT · Nose and paranasal sinuses: allergen immunotherapy

Sample item

A 25-year-old with severe grass pollen rhinitis has poor control despite steroid spray and antihistamines. Which treatment can alter the natural course of the disease?

Original practice item, not a recalled exam question. Nothing here is recorded.

The answer and the reasoning

A. Allergen-specific immunotherapy

Subcutaneous or sublingual allergen immunotherapy induces tolerance and may reduce symptoms for years after stopping. It is considered in patients who fail pharmacotherapy and have a proven IgE-mediated allergy. It requires several years of treatment.

Option by option

  • A. Allergen-specific immunotherapy (correct)

    Correct. Immunotherapy is disease-modifying.

  • B. Topical decongestants

    Decongestants do not change the course of disease.

  • C. Oral montelukast alone

    Montelukast provides symptom relief only.

  • D. Turbinate reduction

    Turbinate surgery treats obstruction only.

Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.

More ENT questions

Questions about this ENT question

What is the answer to this ENT question?

The best answer is A, Allergen-specific immunotherapy. Subcutaneous or sublingual allergen immunotherapy induces tolerance and may reduce symptoms for years after stopping.

Why is "Topical decongestants" not the answer?

Decongestants do not change the course of disease.

Why is "Oral montelukast alone" not the answer?

Montelukast provides symptom relief only.

Why is "Turbinate reduction" not the answer?

Turbinate surgery treats obstruction only.

What concept does this question test?

It tests Nose and paranasal sinuses: allergen immunotherapy in ENT. It is considered in patients who fail pharmacotherapy and have a proven IgE-mediated allergy. It requires several years of treatment.

How hard is this question?

We tag it as an application question: it asks you to use a fact on a patient or a finding. The tag is our own editorial judgement, not an official difficulty rating, so read the reason for every option, not only the answer.

How should I study Nose and paranasal sinuses: allergen immunotherapy?

Learn tuning fork results and audiogram patterns by sketching them. Then use the flashcards and the other ENT questions on this site to test what stuck.

Is this a real NEET PG question?

No. It is an original practice item (editorial status: sample, version 1). NextPrep does not publish recalled or leaked questions, and independent faculty review of this item has not been completed yet, so confirm important facts in a standard textbook.